| Literature DB >> 30542643 |
Yuanyuan Tong1, Jinping Liu1, Lihua Zou2, Zhengyi Feng1, Chun Zhou1, Ruoning Lv1, Yu Jin1.
Abstract
Background: With the widespread application of regional low-flow perfusion (RLFP), development of surgical techniques, and shortened circulatory arrest time, deep hypothermia is indispensable for organ protection. Clinicians have begun to increase the temperature to reduce hypothermia-related adverse outcomes. The aim of this study was to evaluate the safety and efficacy of elevated temperatures during aortic arch surgery with lower body circulatory arrest (LBCA) combined with RLFP.Entities:
Keywords: aortic; cardiopulmonary bypass; lower body circulatory arrest; pediatric; regional low-flow perfusion
Year: 2018 PMID: 30542643 PMCID: PMC6277883 DOI: 10.3389/fped.2018.00356
Source DB: PubMed Journal: Front Pediatr ISSN: 2296-2360 Impact factor: 3.418
Baseline characteristics.
| Males | 41 (65.08) | 67 (60.36) | 23 (69.70) | 0.583 |
| Age (month) | 5.00 [3.00,12.00] | 4.00 [2.00,9.00] | 5.50 [3.00,8.50] | 0.335 |
| Neonates | 5 (7.94) | 16 (14.41) | 2 (6.06) | 0.242 |
| Weight (kg) | 5.60 [4.50,7.40] | 5.5 [4.2,7.5] | 6.4 [4.85,7.8] | 0.534 |
| Height (meter) | 0.62 [0.56, 0.71] | 0.62 [0.56, 0.68] | 0.64 [0.59. 0.67] | 0.329 |
| BSA (m2) | 0.30 [0.26,0.38] | 0.30 [0.24,0.36] | 0.32 [0.27,0.37] | 0.303 |
| EF (%, median) | 65.00 [62.25,73.15] | 65.00 [62.20,73.00] | 65.00 [60.00,70.00] | 0.632 |
| 3 | 40 (63.49) | 69 (62.16) | 28 (84.85) | 0.046 |
| 4 | 23 (36.51) | 42 (37.84) | 5 (15.15) | 0.046 |
| IAA | 26 (41.27) | 29 (26.13) | 3 (9.09) | 0.001 |
| iCoA | 32 (50.79) | 66 (59.46) | 26 (78.79) | 0.029 |
| CoA & HAA | 5 (7.94) | 16 (14.41) | 4 (12.12) | 0.431 |
| VSD | 50 (79.37) | 89 (80.18) | 25 (75.76) | 0.859 |
| ASD | 12 (19.05) | 21 (18.92) | 4 (12.12) | 0.642 |
| PDA | 32 (50.79) | 56 (50.45) | 9 (27.27) | 0.049 |
| Mitral valve insufficiency | 13 (20.63) | 18 (16.22) | 6 (18.18) | 0.764 |
| Tricuspid valve insufficiency | 7 (11.11) | 15 (13.51) | 3 (9.09) | 0.754 |
| Patent foramen ovale | 13 (20.63) | 31 (27.93) | 5 (15.15) | 0.252 |
| Mitral valve stenosis | 2 (3.17) | 1 (0.90) | 1 (3.03) | 0.500 |
| Aortic valve stenosis | 2 (3.17) | 4 (3.60) | 0 (0.00) | 0.483 |
Values are number (%); median, [IQR] or mean ± standard deviation unless otherwise indicated.
Neonates was defined as age ≤ 28 days at operation. BSA, body surface area; EF, ejection fraction; RACHS, Risk Adjustment for Congenital Heart Surgery-1 score; IAA, interrupted aortic arch; CoA, aortic coarctation; HAA, Hypoplastic aortic arch; VSD, ventricular septal defect; ASD, atrial septal defect; PDA patent ductus arteriosus.
Details during RLFP and LBCA.
| CPB duration (min) | 122.00 [110.00,141.00] | 112.00 [93.00,127.00] | 83.00 [75.00,102.50] | 0.000 |
| Myocardial ischemic duration (min) | 74.00 [64.00,85.00] | 67.00 [44.00,85.00] | 28.00 [21.50,38.00] | 0.000 |
| LBCA duration (min) | 29.00 [25.00,38.00] | 25.00 [16.00,32.00] | 18.00 [14.00,24.00] | 0.000 |
| RLFP flow volume (ml/kg) | 32.00 [25.00,38.69] | 37.27 [31.76,45.29] | 52.30 [41.83,62.18] | 0.000 |
| MAP (mmHg) | 31.00 [30.00,39.00] | 32.00 [30.00,37.00] | 31.00 [30.00,36.5] | 0.923 |
| Nasopharyngeal temperature (°C) | 23.43 ± 1.29 | 27.59 ± 1.58 | 31.86 ± 1.11 | 0.000 |
| Rectal temperature (°C) | 26.89 ± 1.92 | 30.19 ± 2.05 | 34.08 ± 1.28 | 0.000 |
| Cerebral-myocardial perfusion (%) | 0 (0.00) | 27 (24.32) | 31 (93.94) | 0.000 |
| Urine output during surgery (ml/kg) | 4.00 [1.00,7.00] | 4.17 [0.98,7.58] | 5.00 [2.49,12.70] | 0.101 |
Values are number (%); median, [IQR] or mean ± standard deviation unless otherwise indicated. CPB, cardiopulmonary bypass; LBCA, lower body circulatory arrest; RLFP, regional low flow perfusion; MAP, mean artery pressure.
Intra-hospital morbidities and recovery outcomes.
| NS complications (%) | 1 (1.59) | 0 (0.00) | 0 (0.00) | 0.303 |
| AKI-1 (%) | 16 (25.40) | 42 (37.84) | 17 (51.52) | 0.036 |
| AKI-2 (%) | 16 (25.40) | 18 (16.22) | 4 (12.12) | 0.194 |
| AKI-3 (%) | 3 (4.76) | 2 (1.80) | 1 (3.03) | 0.548 |
| Peritoneal dialysis (%) | 1 (1.59) | 1 (0.90) | 1 (3.03) | 0.698 |
| Hepatic dysfunction (%) | 29 (46.03) | 57 (51.35) | 16 (48.48) | 0.793 |
| 30-day hospital mortality | 2 (3.17) | 1 (0.90) | 2 (6.06) | 0.237 |
| Delayed extubation | 20 (31.75) | 25 (22.52) | 5 (15.15) | 0.165 |
| Prolonged Hospital stay | 30 (47.62) | 32 (28.83) | 6 (18.18) | 0.006 |
| Intubation time(h) | 27.00 [20.00,50.50] | 25.00 [18.00,45.00] | 18.00 [12.00,23.00] | 0.006 |
| ICU stay(h) | 108.00 [49.00,163.00] | 70.00 [42.00,139.50] | 72.00 [25.25,112.25] | 0.063 |
| Post-op Hospital stay(h) | 13.00 [10.00,18.00] | 11.00 [7.00,14.00] | 10.00 [7.00,12.50] | 0.009 |
| Anesthesia recovery time(h) | 2.00 [1.25,3.50] | 2.00 [1.00,3.00] | 2.25 [1.75,3.20] | 0.210 |
Values are number (%) unless otherwise indicated. AKI, acute kidney injury; NS, nervous system. Post-op, postoperative.
delayed extubation was defined as mechanical ventilation support time ≥ 48 h.
Prolonged hospital stay was defined as postoperative hospital stay ≥14 days.
Figure 1Univariate analysis and forest plot for Factors Associated with Postoperative AKI-1a. CPB, cardiopulmonary bypass; LBCA, lower body circulatory arrest; RACHS, Risk Adjustment for Congenital Heart Surgery-1 score. aAKI-1 was defined according to KDIGO criterion, calculated as serum creatinine increase to 1.5–1.9 times the baseline value, OR increase ≥0.3 mg/dl (≥26.5 mmol/l) or urine output < 0.5 ml/kg per h for 6–12 h; bCategorical variables, 1 for deep hypothermia, 2 for moderate hypothermia and 3 for mild hypothermia; cCategorical variables, defined as 1 or 0; dCategorical variables, defined as 3 or 4.
Univariate and multivariate analysis for factors associated with prolonged hospital stay a.
| Age (m) | 0.889 | 0.833–0.949 | 0.000 | 0.892 | 0.794–1.002 | 0.055 |
| Weight (kg) | 0.734 | 0.625–0.861 | 0.000 | 0.969 | 0.666–1.409 | 0.868 |
| Height (cm) | 0.935 | 0.902–0.969 | 0.000 | 1.000 | 0.920–1.088 | 0.992 |
| 1 vs. 3 | 4.091 | 1.485–11.270 | 0.006 | 0.644 | 0.121–0.343 | 0.606 |
| 2 vs. 3 | 1.823 | 0.687–4.834 | 0.228 | 0.327 | 0.071–1.501 | 0.150 |
| Male | 1.328 | 0.720–2.449 | 0.363 | |||
| Cerebral-Myocardial perfusion | 0.237 | 0.105–0.536 | 0.001 | 0.290 | 0.072–1.168 | 0.082 |
| CPB time (min) | 1.023 | 1.013–1.034 | 0.000 | 1.014 | 1.000–1.029 | 0.056 |
| Myocardial ischemic duration (min) | 1.023 | 1.013–1.034 | 0.000 | 1.003 | 0.993–1.014 | 0.529 |
| LBCA time (min) | 1.046 | 1.016–1.076 | 0.002 | 1.008 | 0.971–1.046 | 0.681 |
| RACHS scoring | 2.371 | 1.306–4.305 | 0.005 | 1.558 | 0.774–3.135 | 0.214 |
CPB, cardiopulmonary bypass; LBCA, lower body circulatory arrest; RACHS, Risk Adjustment for Congenital Heart Surgery-1 score.
Prolonged hospital stay was defined as postoperative hospital stay ≥14 days.
Categorical variables, 1 for deep hypothermia, 2 for moderate hypothermia and 3 for mild hypothermia.
Categorical variables, defined as 1 or 0.
Categorical variables, defined as 3 or 4.
| 1 | Increase to 1.5–1.9 times the baseline value, OR increase ≥0.3 mg/dl (≥26.5 mmol/l) | < 0.5 ml/kg per h for 6–12 h |
| 2 | Increase to 2–2.9 times the baseline value | < 0.5 ml/kg per h for ≥12 h |
| 3 | Increase >3 times the baseline value, OR SCr ≥4 mg/dl (≥353.6 mmol/l), OR Initiation of renal replacement therapy, OR eGFR < 35 ml/min per 1.73 m2 (< 18 years) | < 0.3 ml/kg per h for ≥24 h, ORAnuria for ≥12 h |